Back to Browse Journals » Nursing: Research and Reviews » Volume 3

Why people living with HIV/AIDS exclude individuals from their chosen families

Authors Grant JS, Vance DE, White W, Keltner NL, Raper JL

Received 24 October 2012

Accepted for publication 20 November 2012

Published 12 March 2013 Volume 2013:3 Pages 33—42

DOI http://dx.doi.org/10.2147/NRR.S39504

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Joan S Grant,1 David E Vance,1 Worawan White,2 Norman L Keltner,1 James L Raper3

1School of Nursing, University of Alabama at Birmingham, Birmingham, Alabama, 2Department of Nursing, Pensacola State College, Pensacola, Florida, 3School of Medicine, Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA

Abstract: Health professionals can gain a better understanding of key elements of social support by examining reasons why people living with human immunodeficiency virus/acquired immunodeficiency syndrome (PLWH) exclude individuals from their chosen families (ie, families of choice). Our study identified reasons why PLWH excluded specific individuals from their chosen families. This mixed-method design was drawn from a larger study of 150 PLWH, in which 94 self-reported why they excluded individuals from their chosen families. Physical and emotional distance (n = 64; 68.1%); nonsupport, nonacceptance, and harm (n = 25; 26.6%); conditional caring and trust (n = 22; 23.4%); and no blood/familial relationship (n = 13; 13.8%) were the reasons PLWH excluded individuals from their chosen families. Demographic and personal characteristics were unrelated to these themes, supporting the conclusion that reasons for excluding family members are universal and not dependent on particular participant characteristics. For chosen family relationships to develop and exist, these findings emphasize the value of physical and emotional contact between individuals.

Keywords: families, stigma, social networks, human immunodeficiency virus, acquired immunodeficiency syndrome

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

Molecular targets in arthritis and recent trends in nanotherapy

Roy K, Kanwar RK, Kanwar JR

International Journal of Nanomedicine 2015, 10:5407-5420

Published Date: 26 August 2015

Is increasing the dose of Entecavir effective in partial virological responders?

Erturk A, Adnan Akdogan R, Parlak E, Cure E, Cumhur Cure M, Ozturk C

Drug Design, Development and Therapy 2014, 8:621-625

Published Date: 29 May 2014

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

True story about HIV: theory of viral sequestration and reserve infection

Barasa S

HIV/AIDS - Research and Palliative Care 2011, 3:125-133

Published Date: 8 December 2011

Current and developing therapeutic agents in the treatment of Chagas disease

Werner Apt

Drug Design, Development and Therapy 2010, 4:243-253

Published Date: 17 September 2010